Neurodevelopmental disorder
Disease2 papers
Trial sponsors
Company1 trialPhase 399 people
University of North Carolina, Chapel Hill
1 trialPhase 248 people
Funding
National Institute of Mental HealthUS$803.1k1 grant since 2023
Latest
7medRxivHumansPreprint
Plasma tau-217 levels rise early in tuberous sclerosis complex
Log2 ptau-217 concentrations were significantly higher in 63 people with tuberous sclerosis complex than in 116 cognitively unimpaired controls (p <…Log2 ptau-217 concentrations were significantly higher in 63 people with tuberous sclerosis complex than in 116 cognitively unimpaired controls (p < 0.0001).
The European Journal of NeuroscienceReview
Somatic Mosaicism of the Brain: The Functional Implications of Post-Zygotic Mutations to Neural Circuits
Frontiers in EndocrinologyHumans